GALWAY, Ireland, Nov. 5, 2024 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year ...
Medtronic remains an attractive investment ... surgical tools and robots, and patient monitoring systems, among others. MDT’s revenues are well-diversified by segment, with roughly an even ...
Medtronic (NYSE: MDT ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's routinely coming out ...
Martin de Bock receives funding from Novo Nordisk, Medtronic, Ypsomed ... Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately ...
Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...
Medtronic has issued a voluntary recall on some of its insulin pumps over concerns about the length of their battery life. The Dublin-based medical-device maker said Friday that customers of its ...
Shares of Medtronic PLC MDT shed 1.38% to $87.04 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.96% to 5,695.94 and Dow ...